4-(4-Chlorophenyl)-1,2-dimethyl-6-oxo-1,4,5,6-tetrahydro-3-pyridinecarboxylic acid → HCID 178429245, Verbindung
Reaktionsgleichung
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([CH:8]2[CH2:13][C:12](=[O:14])[N:11]([CH3:15])[C:10]([CH3:16])=[C:9]2[C:17]([OH:19])=O)=[CH:4][CH:3]=1.[NH2:20][C:21]1[CH:22]=[C:23]2[C:27](=[CH:28][CH:29]=1)[NH:26][N:25]=[C:24]2[Cl:30]>>[Cl:30][C:24]1[C:23]2[C:27](=[CH:28][CH:29]=[C:21]([NH:20][C:17]([C:9]3[CH:8]([C:5]4[CH:4]=[CH:3][C:2]([Cl:1])=[CH:7][CH:6]=4)[CH2:13][C:12](=[O:14])[N:11]([CH3:15])[C:10]=3[CH3:16])=[O:19])[CH:22]=2)[NH:26][N:25]=1Komponenten
3
Versuchsvorschrift
The title compound was prepared from the product of Example 56, Step 2 and 5-amino-3-chloroindazole using the method described in Example 56, Step 3. MS (ES+) m/e 430 [M+H]+
Quellen und Nachweise
- ORD-Eintrag
- ord-6c81e3d7967347669cc106cd96659a2f
- Quelldatensatz
- uspto-grants-2009_09